Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 604113

JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms

Naćinović Duletić, Antica; Dekanić, Andrea; Hadžisejdić, Ita; Kušen, Ivona; Matušan-Ilijaš, Koviljka; Grohovac, Dragana; Grahovac, Blaženka; Jonjić, Nives
JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms // Collegium antropologicum, 36 (2012), 3; 859-865 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 604113 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms

Autori
Naćinović Duletić, Antica ; Dekanić, Andrea ; Hadžisejdić, Ita ; Kušen, Ivona ; Matušan-Ilijaš, Koviljka ; Grohovac, Dragana ; Grahovac, Blaženka ; Jonjić, Nives

Izvornik
Collegium antropologicum (0350-6134) 36 (2012), 3; 859-865

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
JAK2-V617F; essential thrombocythemia; polycythemia vera; primary myelofibrosis
(JAK2-V617F; essential thrombocythemia; polycythemia vera; primary myelofibrosis.)

Sažetak
The aim of this study is to investigate the differences of clinical and laboratory parameters between patients with JAK2-V617F positive myeloproliferative neoplasms (MPNs) and JAK2 wild type MPNs. DNA was isolated from peripheral blood granulocytes of 106 patients treated at Rijeka University Hospital Center: 41 with polycythemia vera (PV), 43 with essential thrombocythemia (ET), 9 with primary myelofibrosis (PMF) and 13 with myeloproliferative neoplasm- -unclassifiable (MPN-u). The JAK2-V617F mutation was detected using allele specific PCR. Laboratory and clinical parameters were obtained from patient’s medical records. The JAK2-V617F mutation was detected in 69% (73/106) patients with MPNs. The results revealed significantly different prevalence of JAK2-V617F mutation, between MPNs entities: 88% in PV, 58% in ET, 56% in PMF and 54% in MPNs-unclassified disorders. The JAK2-V617F mutation significantly correlated with higher leukocyte count and alkaline phosphatase score in ET group and with higher platelets count, leukocyte alkaline phosphatase score and serum lactate dehydrogenase in PV group. Vascular events were associated with elevated platelets count in wholeMPNs group, with higher platelets and leukocyte count in ET and with splenomegaly in PV patients. Clinical and laboratory data revealed significant contribution of JAK2-V617F mutation to the development of clinical phenotype in patients with distinct subgroups of MPNs.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Projekti:
062-0620095-0082 - REGULACIJSKI ČIMBENICI ANGIOGENEZE U PROGNOZI TUMORA (Jonjić, Nives, MZOS ) ( CroRIS)
062-1081872-0091 - Angiogeneza u agresivnih ne-Hodgkinovih limfoma (Duletić-Načinović, Antica, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka

Profili:

Avatar Url Nives Jonjić (autor)

Avatar Url Ita Hadžisejdić (autor)

Avatar Url Andrea Dekanić (autor)

Avatar Url Dragana Grohovac (autor)

Avatar Url Blaženka Grahovac (autor)

Avatar Url Koviljka Matušan Ilijaš (autor)

Poveznice na cjeloviti tekst rada:

Pristup cjelovitom tekstu rada Hrčak

Citiraj ovu publikaciju:

Naćinović Duletić, Antica; Dekanić, Andrea; Hadžisejdić, Ita; Kušen, Ivona; Matušan-Ilijaš, Koviljka; Grohovac, Dragana; Grahovac, Blaženka; Jonjić, Nives
JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms // Collegium antropologicum, 36 (2012), 3; 859-865 (međunarodna recenzija, članak, znanstveni)
Naćinović Duletić, A., Dekanić, A., Hadžisejdić, I., Kušen, I., Matušan-Ilijaš, K., Grohovac, D., Grahovac, B. & Jonjić, N. (2012) JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms. Collegium antropologicum, 36 (3), 859-865.
@article{article, author = {Na\'{c}inovi\'{c} Duleti\'{c}, Antica and Dekani\'{c}, Andrea and Had\v{z}isejdi\'{c}, Ita and Ku\v{s}en, Ivona and Matu\v{s}an-Ilija\v{s}, Koviljka and Grohovac, Dragana and Grahovac, Bla\v{z}enka and Jonji\'{c}, Nives}, year = {2012}, pages = {859-865}, keywords = {JAK2-V617F, essential thrombocythemia, polycythemia vera, primary myelofibrosis}, journal = {Collegium antropologicum}, volume = {36}, number = {3}, issn = {0350-6134}, title = {JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms}, keyword = {JAK2-V617F, essential thrombocythemia, polycythemia vera, primary myelofibrosis} }
@article{article, author = {Na\'{c}inovi\'{c} Duleti\'{c}, Antica and Dekani\'{c}, Andrea and Had\v{z}isejdi\'{c}, Ita and Ku\v{s}en, Ivona and Matu\v{s}an-Ilija\v{s}, Koviljka and Grohovac, Dragana and Grahovac, Bla\v{z}enka and Jonji\'{c}, Nives}, year = {2012}, pages = {859-865}, keywords = {JAK2-V617F, essential thrombocythemia, polycythemia vera, primary myelofibrosis.}, journal = {Collegium antropologicum}, volume = {36}, number = {3}, issn = {0350-6134}, title = {JAK2-V617F mutation is associated with clinical and laboratory features of myeloproliferative neoplasms}, keyword = {JAK2-V617F, essential thrombocythemia, polycythemia vera, primary myelofibrosis.} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Social Science Citation Index (SSCI)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Podijeli:





Contrast
Increase Font
Decrease Font
Dyslexic Font
CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.